Literature DB >> 25187546

Characterization of simian immunodeficiency virus (SIV) that induces SIV encephalitis in rhesus macaques with high frequency: role of TRIM5 and major histocompatibility complex genotypes and early entry to the brain.

Kenta Matsuda1, Que Dang2, Charles R Brown3, Brandon F Keele4, Fan Wu1, Ilnour Ourmanov1, Robert Goeken1, Sonya Whitted1, Nadeene E Riddick1, Alicia Buckler-White1, Vanessa M Hirsch5.   

Abstract

UNLABELLED: Although nonhuman primate models of neuro-AIDS have made tremendous contributions to our understanding of disease progression in the central nervous system (CNS) of human immunodeficiency virus type 1 (HIV-1)-infected individuals, each model holds advantages and limitations. In this study, in vivo passage of SIVsmE543 was conducted to obtain a viral isolate that can induce neuropathology in rhesus macaques. After a series of four in vivo passages in rhesus macaques, we have successfully isolated SIVsm804E. SIVsm804E shows efficient replication in peripheral blood mononuclear cells (PBMCs) and monocyte-derived macrophages (MDMs) in vitro and induces neuro-AIDS in high frequencies in vivo. Analysis of the acute phase of infection revealed that SIVsm804E establishes infection in the CNS during the early phase of the infection, which was not observed in the animals infected with the parental SIVsmE543-3. Comprehensive analysis of disease progression in the animals used in the study suggested that host major histocompatibility complex class I (MHC-I) and TRIM5α genotypes influence the disease progression in the CNS. Taken together, our findings show that we have successfully isolated a new strain of simian immunodeficiency virus (SIV) that is capable of establishing infection in the CNS at early stage of infection and causes neuropathology in infected rhesus macaques at a high frequency (83%) using a single inoculum, when animals with restrictive MHC-I or TRIM5α genotypes are excluded. SIVsm804E has the potential to augment some of the limitations of existing nonhuman primate neuro-AIDS models. IMPORTANCE: Human immunodeficiency virus (HIV) is associated with a high frequency of neurologic complications due to infection of the central nervous system (CNS). Although the use of antiviral treatment has reduced the incidence of severe complications, milder disease of the CNS continues to be a significant problem. Animal models to study development of neurologic disease are needed. This article describes the development of a novel virus isolate that induces neurologic disease in a high proportion of rhesus macaques infected without the need for prior immunomodulation as is required for some other models.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25187546      PMCID: PMC4249079          DOI: 10.1128/JVI.01996-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  41 in total

1.  HIV and HIV dementia.

Authors:  D L Kolson; F González-Scarano
Journal:  J Clin Invest       Date:  2000-07       Impact factor: 14.808

2.  Efficient transmission and persistence of low-frequency SIVmac251 variants in CD8-depleted rhesus macaques with different neuropathology.

Authors:  Samantha L Strickland; Rebecca R Gray; Susanna L Lamers; Tricia H Burdo; Ellen Huenink; David J Nolan; Brian Nowlin; Xavier Alvarez; Cecily C Midkiff; Maureen M Goodenow; Kenneth Williams; Marco Salemi
Journal:  J Gen Virol       Date:  2012-02-01       Impact factor: 3.891

3.  Infectious molecular clones from a simian immunodeficiency virus-infected rapid-progressor (RP) macaque: evidence of differential selection of RP-specific envelope mutations in vitro and in vivo.

Authors:  Takeo Kuwata; Houman Dehghani; Charles R Brown; Ronald Plishka; Alicia Buckler-White; Tatsuhiko Igarashi; Joseph Mattapallil; Mario Roederer; Vanessa M Hirsch
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

4.  Simian immunodeficiency virus mac251 infection of astrocytes.

Authors:  G Guillemin; J Croitoru; R L Le Grand; M Franck-Duchenne; D Dormont; F D Boussin
Journal:  J Neurovirol       Date:  2000-06       Impact factor: 2.643

5.  HIV-1 infection of subcortical astrocytes in the pediatric central nervous system.

Authors:  C Tornatore; R Chandra; J R Berger; E O Major
Journal:  Neurology       Date:  1994-03       Impact factor: 9.910

Review 6.  The brain in AIDS: central nervous system HIV-1 infection and AIDS dementia complex.

Authors:  R W Price; B Brew; J Sidtis; M Rosenblum; A C Scheck; P Cleary
Journal:  Science       Date:  1988-02-05       Impact factor: 47.728

7.  Early events in tissues during infection with pathogenic (SIVmac239) and nonpathogenic (SIVmac1A11) molecular clones of simian immunodeficiency virus.

Authors:  A A Lackner; P Vogel; R A Ramos; J D Kluge; M Marthas
Journal:  Am J Pathol       Date:  1994-08       Impact factor: 4.307

8.  The primary phase of infection by pathogenic simian-human immunodeficiency virus results in disruption of the blood-brain barrier.

Authors:  Edward B Stephens; Dinesh K Singh; M Eric Kohler; Mollie Jackson; Erik Pacyniak; Nancy E J Berman
Journal:  AIDS Res Hum Retroviruses       Date:  2003-10       Impact factor: 2.205

9.  Neuropathology of AIDS: An Autopsy Review of 284 Cases from Brazil Comparing the Findings Pre- and Post-HAART (Highly Active Antiretroviral Therapy) and Pre- and Postmortem Correlation.

Authors:  Ana Cristina Araújo Lemos Silva; Blenda Sousa Carli Rodrigues; Adilha Misson Rua Micheletti; Sebastião Tostes; Antonio Carlos Oliveira Meneses; Mário Leon Silva-Vergara; Sheila Jorge Adad
Journal:  AIDS Res Treat       Date:  2012-02-22

10.  Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1.

Authors:  Brandon F Keele; Hui Li; Gerald H Learn; Peter Hraber; Elena E Giorgi; Truman Grayson; Chuanxi Sun; Yalu Chen; Wendy W Yeh; Norman L Letvin; John R Mascola; Gary J Nabel; Barton F Haynes; Tanmoy Bhattacharya; Alan S Perelson; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-05-04       Impact factor: 14.307

View more
  15 in total

Review 1.  Brain PET Imaging: Value for Understanding the Pathophysiology of HIV-associated Neurocognitive Disorder (HAND).

Authors:  Sanhita Sinharay; Dima A Hammoud
Journal:  Curr HIV/AIDS Rep       Date:  2019-02       Impact factor: 5.071

2.  Enhanced antagonism of BST-2 by a neurovirulent SIV envelope.

Authors:  Kenta Matsuda; Chia-Yen Chen; Sonya Whitted; Elena Chertova; David J Roser; Fan Wu; Ronald J Plishka; Ilnour Ourmanov; Alicia Buckler-White; Jeffrey D Lifson; Klaus Strebel; Vanessa M Hirsch
Journal:  J Clin Invest       Date:  2016-05-09       Impact factor: 14.808

Review 3.  Macrophages in Progressive Human Immunodeficiency Virus/Simian Immunodeficiency Virus Infections.

Authors:  Sarah R DiNapoli; Vanessa M Hirsch; Jason M Brenchley
Journal:  J Virol       Date:  2016-08-12       Impact factor: 5.103

4.  Tissue-resident macrophages can contain replication-competent virus in antiretroviral-naive, SIV-infected Asian macaques.

Authors:  Sarah R DiNapoli; Alexandra M Ortiz; Fan Wu; Kenta Matsuda; Homer L Twigg; Vanessa M Hirsch; Kenneth Knox; Jason M Brenchley
Journal:  JCI Insight       Date:  2017-02-23

5.  Endothelial cells are a replicative niche for entry of Toxoplasma gondii to the central nervous system.

Authors:  Christoph Konradt; Norikiyo Ueno; David A Christian; Jonathan H Delong; Gretchen Harms Pritchard; Jasmin Herz; David J Bzik; Anita A Koshy; Dorian B McGavern; Melissa B Lodoen; Christopher A Hunter
Journal:  Nat Microbiol       Date:  2016-02-15       Impact factor: 17.745

Review 6.  Non-human primate models of SIV infection and CNS neuropathology.

Authors:  Kenneth Williams; Andrew Lackner; Jaclyn Mallard
Journal:  Curr Opin Virol       Date:  2016-08-18       Impact factor: 7.090

7.  TRIM5α Resistance Escape Mutations in the Capsid Are Transferable between Simian Immunodeficiency Virus Strains.

Authors:  Fan Wu; Andrea Kirmaier; Ellen White; Ilnour Ourmanov; Sonya Whitted; Kenta Matsuda; Nadeene Riddick; Laura R Hall; Jennifer S Morgan; Ronald J Plishka; Alicia Buckler-White; Welkin E Johnson; Vanessa M Hirsch
Journal:  J Virol       Date:  2016-11-28       Impact factor: 5.103

8.  Derivation and Characterization of Pathogenic Transmitted/Founder Molecular Clones from Simian Immunodeficiency Virus SIVsmE660 and SIVmac251 following Mucosal Infection.

Authors:  Michael J Lopker; Gregory Q Del Prete; Jacob D Estes; Hui Li; Carolyn Reid; Laura Newman; Leslie Lipkey; Celine Camus; Juliet L Easlick; Shuyi Wang; Julie M Decker; Katharine J Bar; Gerald Learn; Ranajit Pal; Deborah E Weiss; Beatrice H Hahn; Jeffrey D Lifson; George M Shaw; Brandon F Keele
Journal:  J Virol       Date:  2016-09-12       Impact factor: 6.549

Review 9.  HIV-1 and drug abuse comorbidity: Lessons learned from the animal models of NeuroHIV.

Authors:  Susmita Sil; Annadurai Thangaraj; Ernest T Chivero; Fang Niu; Muthukumar Kannan; Ke Liao; Peter S Silverstein; Palsamy Periyasamy; Shilpa Buch
Journal:  Neurosci Lett       Date:  2021-03-29       Impact factor: 3.197

10.  A SIV molecular clone that targets the CNS and induces neuroAIDS in rhesus macaques.

Authors:  Kenta Matsuda; Nadeene E Riddick; Cheri A Lee; Sarah B Puryear; Fan Wu; Bernard A P Lafont; Sonya Whitted; Vanessa M Hirsch
Journal:  PLoS Pathog       Date:  2017-08-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.